Liu, R.; Ding, Y.; Xu, Y.; Wu, Q.; Chen, Y.; Yan, G.; Yin, D.; Yang, Y.
Engineering a Dual-Function Starch–Cellulose Composite for Colon-Targeted Probiotic Delivery and Synergistic Gut Microbiota Regulation in Type 2 Diabetes Therapeutics. Pharmaceutics 2025, 17, 663.
https://doi.org/10.3390/pharmaceutics17050663
AMA Style
Liu R, Ding Y, Xu Y, Wu Q, Chen Y, Yan G, Yin D, Yang Y.
Engineering a Dual-Function Starch–Cellulose Composite for Colon-Targeted Probiotic Delivery and Synergistic Gut Microbiota Regulation in Type 2 Diabetes Therapeutics. Pharmaceutics. 2025; 17(5):663.
https://doi.org/10.3390/pharmaceutics17050663
Chicago/Turabian Style
Liu, Ruixiang, Yikang Ding, Yujing Xu, Qifeng Wu, Yanan Chen, Guiming Yan, Dengke Yin, and Ye Yang.
2025. "Engineering a Dual-Function Starch–Cellulose Composite for Colon-Targeted Probiotic Delivery and Synergistic Gut Microbiota Regulation in Type 2 Diabetes Therapeutics" Pharmaceutics 17, no. 5: 663.
https://doi.org/10.3390/pharmaceutics17050663
APA Style
Liu, R., Ding, Y., Xu, Y., Wu, Q., Chen, Y., Yan, G., Yin, D., & Yang, Y.
(2025). Engineering a Dual-Function Starch–Cellulose Composite for Colon-Targeted Probiotic Delivery and Synergistic Gut Microbiota Regulation in Type 2 Diabetes Therapeutics. Pharmaceutics, 17(5), 663.
https://doi.org/10.3390/pharmaceutics17050663
